Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-21

Clinical Trial Update: Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating prazosin for combat-related PTSD nightmares and sleep disturbance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin (prazosin)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Stress Disorder, Post-Traumatic | Phase 4 | Status: COMPLETED